Founders
Meet our Founders
Dr. Anand Srivastava
President MS, Ph.D.
Chairman and Co-founder
Global Institute of Stem Cell Therapy and Research San Diego, California 92122, U.S.A.
About
Dr. Anand Srivastava has been associated with leading universities and research institutions of USA. In affiliation with University of California San Diego Medical College (UCSD), University of California Irvine Medical College (UCI), Salk Research Institute, San Diego, Burnham Institute for Medical Research, San Diego, University of California Los Angeles Medical College (UCLA), USA has developed several research projects and has an extensive research experience in the field of Stem cell which is documented by several publications in revered scientific journals.
Dr. Anand Srivastava’s success has its root in his unique background of expertise in Stem cell biology, protein biochemistry, molecular biology, immunology, in utero transplantation of stem cell, tissue targeting, gene therapy and clinical research. There are many scientists who can work in a narrowly defined field but few have broad and multidisciplinary experience to carry out clinical research in a field as challenging as Stem cell biology, cancer and gene therapy field. Dr. Anand Srivastava’s wide-spectrum expertise is rare in clinical research and perfectly crafted to fit ideally with the GIOSTAR projects for Stem cell transplant, cancer and gene therapy research.
Dr. Anand Srivastava’s research work has been presented in various national and international scientific meetings and conferences in India, Japan, Germany and USA. His research articles have been published in peer reviewed medical scientific journals and his work has been cited extensively by other scientists. Dr. Anand Srivastava’s expertise and scientific achievements were recognized by many scientific fellowships and by two consecutive awards of highly prestigious and internationally recognized, JISTEC award from Science and Technology Agency, Government of Japan. Also, his research presentation was awarded with the excellent presentation award in the “Meeting of Clinical Chemistry and Medicine, Kyoto, Japan. He has also expertise in genetic engineering research, developmental biology, immunology, making the transgenic animals and his extraordinary expertise of searching and characterizing the new genes are ideal for our ongoing projects of developing the effective treatments for many degenerative diseases, genetic diseases and cancer. Based on his extraordinary scientific achievements his biography has been included in “WHO IS WHO IN AMERICA” data bank two times, first in 2005 and second in 2010. He has been bestowed upon USA Congressional Recognition for his contribution in the field of Stem Cell Science.
Dr. Srivastava is a Chairman and Cofounder of California based Global Institute of Stem Cell Therapy and Research (GIOSTAR) headquartered in San Diego, California, (U.S.A.). The company was formed with the vision to provide stem cell-based therapy to aid those suffering from degenerative or genetic diseases around the world such as Parkinson’s, Alzheimer’s, Autism, Diabetes, Heart Disease, Stroke, Spinal Cord Injuries, Paralysis, Blood Related Diseases, Cancer and Burns. GIOSTAR is a leader in developing most advance stem cell-based technology, supported by leading scientists with the pioneering publications in the area of stem cell biology. Company’s primary focus is to discover and develop a cure for human diseases with the state-of-the-art unique stem cell-based therapies and products. The Regenerative Medicine provides promise for treatments of diseases previously regarded as incurable.
Expertise of Dr. Anand Srivastava
Dr. Anand Srivastava has his expertise in the following areas:
Stem cell biology
Protein biochemistry
Molecular biology
Immunology
In-Vitro transplantation of stem cell
Tissue targeting
Gene therapy
Clinical research
Special Stem Issues of Journals Devoted to Dr. Srivastava
Current Topics of Medicinal Chemistry among top five medicinal chemistry journal devoted its special issue of stem cell to Dr. Srivastava in 2010.
Stem Cell International devoted its special issue on stem cells to Dr. Srivastava in 2012.
Potentials of ES cell therapy in neurodegenerative diseases (Curr Pharm Des; 2008; 14:3873- 9) by Dr. Srivastava is still holding number one position among top 20 articles published since 2008 in the field rated by BioMedLib in 2012.
Dr. Srivastava has Contributed for Stem Cell Programs and Guided Stem Cell Policies and Programs or Following Governments and Private Organizations:
Helped stem cell core facility at Salk Research Institute, San Diego, USA
Worked for stem cell program at University of California, Los Angeles, USA
Worked for Japanese Research Institute for developing genomic program, Japan
Guided scientists in developing stem cell program for Turkey, Kuwait and Saudi Arabia
Stem cell program Director of GIOSTAR for State of Gujarat, India
Stem cell program Director of GIOSTAR for State of Madhya Pradesh, India
Stem cell program Director of GIOSTAR for State of Chhattisgarh, India
Stem cell program Director of GIOSTAR for University of Baroda, Gujarat, India
Stem Cell program advisor for Asian Medical School, Kyrgyzstan
Mr. Deven Patel – President, CEO and Co-founder
Mr. Deven Patel, is the CEO, President and Cofounder of Global Institute of Stem Cell Therapy and Research (GIOSTAR) headquartered in San Diego, California, U.S.A. GIOSTAR was formed with the vision to provide affordable stem cell based therapies to the masses around the world suffering from degenerative or genetic diseases and unable to afford today’s high cost of the treatment.
GIOSTAR is in process of opening Institutes of Regenerative Medicine and Stem cell Research and Treatment Hospitals/Centers worldwide in many different countries including USA, India, China, Thailand, Dubai, Philippines, Brazil, Sweden, Turkey, Columbia and Bahamas. Honorable Prime Minister of India, Mr. Narendra Modi has inaugurated GIOSTAR’s state of the art,world’s first, dedicated stem cell treatment Hospital in Ahmedabad, Gujarat State, India in July 2011. GIOSTAR is in process of opening five more hospitals just in India with in next three years.
GIOSTAR under the leadership of Mr. Patel is in charge of developing stem cell transplant program for four different State Governments in India with total population of approx. 155 million. GIOSTAR is pleased to announce that, in collaborations with Government of Gujarat, India, world’s largest state of the art Stem Cell Treatment Hospital is taking shape in Surat Civil Hospital Campus. The four State Governments in India with help of GIOSTAR’s stem cell science are preparing to treat the large, poor populations in India suffering from sickle cell anemia and thalassemia. GIOSTAR is in negotiations with China’s public and private sector to start stem cell transplant program at ten different locations. GIOSTAR is involved in helping few world Governments to develop stem cell program policies in their respective countries.
Mr. Patel has served as the CEO, President and Board of Directors in highly comprehensive industries such as Healthcare, Stem Cell Research, Architectural, General Construction, Alternative Energy and Multifaceted Internet industries. Mr. Patel has served as the President of Federation of India Associations San Diego (FIA-SD) Mr. Patel has also served in key positions of several public and private organizations such as GIOSTAR Foundation, Asian and Pacific American Coalition (APAC), Asian Business Association, Reality Changers, CRY America, Global Organization of People of Indian Origin. He has also served as Vice President of newly formed San Diego United Lion’s Club.
Mr. Patel has served as the founding President of Asian and Pacific American Coalition (APAC) representing San Diego, California API communities from nine Asian countries and spearheaded its efforts in 2011 at City Hall to create the new 9th City Council District in City of San Diego to be an Asian Pacific American influenced district through the redistricting process.
He was honored with USA Congressional Recognition for his efforts in spreading the advancement stem cell science around the world. He was also bestowed upon Asian Heritage Award for his business leadership in the field of stem cell science.
Mr. Siddharth Bhavsar, MS, MBA – Co-Founder & Chief Operating Officer
Mr. Siddharth Bhavsar has over 10 years of experience working on key projects in a broad spectrum of industries including Healthcare, Life Sciences, High-tech, Software & Internet, with a wide range of companies including Fortune 500 companies (Philips Healthcare, General Electric, Microsoft, Hitachi), government (National Institute of Health), Start-Ups and Non-Profits. His projects covered corporate finance, developing business plans, raising venture capital, performing investment analysis, strategy development, business process improvement, operations, marketing, M&A, partnership development and post merger integration. His international projects footprint spans USA, India, Netherlands, China, Japan and New Zealand. He also has experience of working in Private Equity, launching international operations for companies and turning around failing organizations. He has consistently been a recipient of a number of awards for excellence in his academic & professional pursuits including a National Merit Scholarship, Academic Achievement award, Philips Ovation Award, Philips Healthcare trasPHorm award among others. He also holds a patent in Cardiology Information Systems. He has an M.S in Computer Science from USC and an MBA from UCLA Anderson School of Management where he has held a number of Director level positions and was most recently an officer for Technology Incubation on the Board of Entrepreneurs’ Association.